Sandoz Group AG (OTCMKTS:SDZNY – Get Free Report)’s stock price hit a new 52-week high during trading on Thursday . The stock traded as high as $47.96 and last traded at $47.76, with a volume of 26618 shares. The stock had previously closed at $46.85.
Analyst Upgrades and Downgrades
Separately, BNP Paribas cut Sandoz Group from a “strong-buy” rating to a “hold” rating in a report on Monday, December 2nd.
View Our Latest Report on SDZNY
Sandoz Group Stock Performance
Sandoz Group Company Profile
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Recommended Stories
- Five stocks we like better than Sandoz Group
- The Risks of Owning Bonds
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- What is the Shanghai Stock Exchange Composite Index?
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- What is a Low P/E Ratio and What Does it Tell Investors?
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
